A series of aryltropane-based bivalent ligands was prepared and investigated for binding potency and for their ability to inhibit reuptake of human dopamine, serotonin and norepinephrine transporters. The bivalent ligand 4, comprised of linking an aryltropane by an octamethylene spacer showed high efficacy for the human dopamine transporter and had a discrimination ratio of 130. (C) 2003 Elsevier Science Ltd. All rights reserved.
作者:Keith Fandrick、Xianqi Feng、Aaron Janowsky、Robert Johnson、John R Cashman
DOI:10.1016/s0960-894x(03)00386-x
日期:2003.7
A series of aryltropane-based bivalent ligands was prepared and investigated for binding potency and for their ability to inhibit reuptake of human dopamine, serotonin and norepinephrine transporters. The bivalent ligand 4, comprised of linking an aryltropane by an octamethylene spacer showed high efficacy for the human dopamine transporter and had a discrimination ratio of 130. (C) 2003 Elsevier Science Ltd. All rights reserved.